Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 0 | 5,000 | 0 | 25,191 | 1,283 |
| Cost of Goods | N/A | N/A | N/A | N/A | 27 |
| Gross Profit | N/A | 5,000 | N/A | 25,191 | 1,256 |
| Operating Expenses | 27,079 | 33,749 | 21,215 | 15,376 | 52,324 |
| Operating Income | -27,079 | -28,749 | -21,215 | 9,815 | -51,041 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,665 |
| Other Income | 1,719 | 380 | 764 | 667 | 0 |
| Pre-tax Income | -25,360 | -28,369 | -20,451 | 10,482 | -52,706 |
| Net Income Continuous | -25,360 | -28,369 | -20,451 | 10,482 | -52,706 |
| Net Income Discontinuous | N/A | 246 | 120 | 3 | -175 |
| Net Income Extraordinary | 2,639 | 0 | 0 | N/A | N/A |
| Net Income | $-22,721 | $-28,123 | $-20,331 | $10,485 | $-52,881 |
| EPS Basic Total Ops | -0.32 | -0.42 | -0.34 | 0.21 | -1.18 |
| EPS Basic Continuous Ops | -0.36 | -0.42 | -0.34 | 0.21 | -1.17 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.32 | -0.42 | -0.34 | 0.21 | -1.18 |
| EPS Diluted Continuous Ops | -0.36 | -0.42 | -0.34 | 0.21 | -1.17 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.36 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-27,044 | $-28,702 | $-21,155 | $9,907 | $-50,930 |